Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribonuclease H2 subunit C pseudogene 1 (RNASEH2CP1)
- Target
- RNASEH2CP1
- Molecular classification
- Other (Pseudogene)
01
Overview
Ribonuclease H2 subunit C pseudogene 1 (RNASEH2CP1, also known as AYP1p1) is a pseudogene related to the functional ribonuclease H2 subunit C gene (RNASEH2C). Pseudogenes are genomic sequences similar to known genes but usually lack the ability to encode a functional protein. RNASEH2CP1 does not serve known biological roles and is not considered a therapeutic or diagnostic target. For research and clinical purposes, the functional protein-coding gene RNASEH2C is relevant, as it is implicated in cellular DNA replication, DNA repair, and genetic diseases such as Aicardi-Goutières syndrome. If your interest is in ribonuclease H2 subunit C as a therapeutic target, you should refer to the functional gene RNASEH2C. RNASEH2CP1, being a pseudogene, is not relevant for drug targeting, clinical biomarkers, or molecular mechanism studies.
- Other names
- Ribonuclease H2 subunit C pseudogene 1RNASEH2CP1AYP1p1
02
Mechanism of action
None (not applicable; no drugs target this pseudogene)
03
Biological functions
None (no established biological function; pseudogenes generally do not encode functional products)
04
Disease associations
None. No disease association is reported for RNASEH2CP1; disease associations exist for RNASEH2C (such as Aicardi-Goutières syndrome)
05
Safety considerations
None; as RNASEH2CP1 is not a therapeutic target, there are no safety concerns or therapeutic challenges related to it.
06
Interacting drugs
None (no drugs target RNASEH2CP1; drugs have been studied for pathways involving the functional RNASEH2C subunit, particularly in DNA repair and cancer research, but not for the pseudogene itself)
07
Biomarkers
None (RNASEH2CP1 is not used as a biomarker; RNASEH2A and RNASEH2C can be used as biomarkers for some diseases and cancer progression, but RNASEH2CP1 is not relevant)
Beyond the preview
Go deeper on Ribonuclease H2 subunit C pseudogene 1 (RNASEH2CP1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribonuclease H2 subunit C pseudogene 1 (RNASEH2CP1).